TAPCOM combination ophthalmic solution for glaucoma and ocular hypertension (tafluprost, timolol maleate)

What is TAPCOM combination ophthalmic solution for glaucoma and ocular hypertension (tafluprost, timolol maleate)?

The TAPCOM ophthalmic solution presents a robust strategy for addressing glaucoma and ocular hypertension. Utilizing the active components tafluprost and timolol maleate, this medication synergistically targets the underlying factors contributing to elevated intraocular pressure, thereby providing effective relief for patients.

Central to the mechanism of action of TAPCOM are its two primary ingredients. Tafluprost works by inhibiting beta-receptors, thereby decreasing the production of aqueous humor, the fluid responsible for regulating eye pressure. Concurrently, timolol maleate stimulates the prostanoid FP receptor, facilitating the drainage of aqueous humor and further aiding in pressure reduction within the eye. This innovative combination not only addresses multiple pathways involved in intraocular pressure regulation but also demonstrates superior efficacy compared to individual components.

Numerous studies and clinical trials have consistently shown the effectiveness of tafluprost and timolol maleate in lowering intraocular pressure, solidifying TAPCOM as a dependable choice for managing glaucoma and ocular hypertension. For instance, in the study titled "Tafluprost for the Reduction of Intraocular Pressure in Open Angle Glaucoma and Ocular Hypertension," researchers highlighted tafluprost's strong affinity for the prostanoid FP receptor, emphasizing the specificity and potency of TAPCOM's active ingredients in targeting the root causes of elevated intraocular pressure.

Patients seeking trustworthy treatment for glaucoma or ocular hypertension can rely on TAPCOM to deliver consistent results. By harnessing the benefits of tafluprost and timolol maleate, this ophthalmic solution offers a comprehensive approach to managing these conditions, supporting patients in maintaining optimal eye health and vision.

Active principles: tafluprost, timolol maleate

Amount: 5 bottles * 2.5 ml

Indications: treatment of glaucoma and ocular hypertension

How to take: Apply 1 drop at a time, once a day.

Contraindications and precautions: Patients with contact lenses must take off the lenses before applying and wait at least 5-10 minutes after applying before wearing the lenses again. Never apply while wearing contact lenses. This medication may temporarily induce blurred vision upon application. Avoid operating machinery or driving a vehicle until these symptoms subside. Do not expose to sunlight or heat. If any unusual symptoms like iris color change occur, discontinue use and consult with your doctor. Do not use in the following cases:

• pregnancy or breastfeeding,
• bronchial asthma or history of it, bronchospasm, chronic obstructive pulmonary disease,
• heart failure, sinus bradycardia, atrioventricular block, cardiogenic shock, right-sided heart failure secondary to pulmonary hypertension, congestive heart failure, 
• diabetic ketoacidosis, metabolic acidosis, diabetes, 
• intraocular inflammation (iritis, uveitis), 
• aphakic or pseudophakic eyes.